Early blood test for multiple myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests a new blood test that may help find multiple myeloma and related conditions earlier. It looks at DNA fragments in the blood to see if they can signal the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 40 years old.
- You have been diagnosed with multiple myeloma, smoldering myeloma, or MGUS.
- You have not had any cancer in the past 5 years or received cancer treatment.
- You have not had an organ or bone marrow transplant.
- You have not had a blood transfusion in the last 7 days.
- You are willing to give a blood sample and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced genetic testing to see if they can predict how monoclonal gammopathies (early blood conditions that may turn into cancer) will change over time. It may help doctors understand your risk better.
This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.
This trial tests a new imaging agent (a special dye) to see how it spreads in the body and whether it can help find multiple myeloma spots. It's not a treatment, but it may help doctors see the disease better.
This study looks at whether a simple blood test can help track multiple myeloma. It will measure a protein called soluble BCMA that may indicate how active the disease is, potentially helping doctors monitor patients without frequent bone marrow tests.
This study looks at simple blood test results from people newly diagnosed with multiple myeloma to see if those results can help predict how the disease may progress. It aims to find patterns in the blood that might guide future treatment decisions without any extra procedures or drugs.
This study looks at two different “precursor” conditions that can happen before multiple myeloma: MGUS and smoldering myeloma (SMM). Researchers want to better tell which cases are more likely to progress, using blood/urine tests and sometimes bone marrow tissue.
Hear when a new MGUS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.